Dermatology
Latest News
Expert shares her tips for diagnosing, treating onychomycosis
“We need to be antifungal stewards, because resistant dermatophytes are coming,” Dr. Boni E. Elewski said.
News from the FDA/CDC
Cases of potentially deadly fungus jump 200%: CDC
People in hospitals and nursing homes are at a heightened risk because they might have weakened immune systems or be using invasive medical...
Latest News
Phase 3 prurigo nodularis trial shows positive results for nemolizumab
“The use of topical steroids was not allowed in this trial,” Dr. Shawn G. Kwatra said.
Latest News
Novel therapy shows promise for treating skin-predominant dermatomyositis
The study drug “is a potent, selective humanized IgG1-neutralizing antibody directed at IFN-beta,” said Dr. Aaron Mangold, the principal...
Latest News
Studies validate IL-17 as hidradenitis suppurativa drug target
This clearly validates this target for the control of HS," reported lead investigator Alexa B. Kimball, MD, MPH.
Latest News
Melanoma screening: Consensus statement offers greater clarity
Overall, the panelists agreed that a risk-stratified approach is likely the most appropriate strategy for melanoma screening and follow-up and...
Latest News
Novel single-use patch shows promise for primary axillary hyperhidrosis
“This is a new kind of device that is going to be a nice tool to have.”
Latest News
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatology
The recently approved deucravacitinib is the only JAK inhibitor that has so far been exempt from these warnings.
Conference Coverage
Lanolin gets nod for Allergen of the Year
Controversy continues over lanolin allergenicity; some patients with positive patch tests can tolerate lanolin ingredients.
Latest News
Study finds quality of topical steroid withdrawal videos on YouTube subpar
“We were disheartened that patient testimonial videos had the poorest quality and reliability of the information sources,” Erika McCormick said....
Latest News
Spironolactone: an ‘inexpensive, effective’ option for acne in women
“Spironolactone is fairly accessible, inexpensive, and effective for our patients,” Dr. Julie C. Harper said.